We are live on ! Find out more
ASPN icon

Aspen Aerogels

58 hedge funds and large institutions have $88.1M invested in Aspen Aerogels in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 10

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

10% more capital invested

Capital invested by funds: $80.3M → $88.1M (+$7.84M)

7% more funds holding

Funds holding: 5458 (+4)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.04% less ownership

Funds ownership: 77.36%76.32% (-1%)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
22
Reduced
10
Closed
10
Calls
Puts
Net Calls
Net Calls Change

ASPN Hedge Fund Activity: Q2 2016 in Review

58 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q2 2016, worth a combined $88.1M — up 9.8% from $80.3M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ASPN positions and 10 closed out — a net gain of 5 holders — while 22 added to existing stakes and 10 trimmed.

The largest buyer was Harvey Partners, opening a new position worth an estimated $942K. The largest seller was Fidelity Investments, cutting an estimated $2.5M.

  • 58 institutional investors held Aspen Aerogels (ASPN) as of Q2 2016, up from 54 in Q1 2016.
  • Funds reported $88.1M of Aspen Aerogels stock for Q2 2016, up 9.8% quarter-over-quarter.
  • 15 funds opened new Aspen Aerogels positions in Q2 2016 and 10 closed out, a net change of +5 holders.
  • The largest Aspen Aerogels buyer in Q2 2016 was Harvey Partners, an estimated $942K added.
  • The largest Aspen Aerogels seller in Q2 2016 was Fidelity Investments, an estimated $2.5M sold.

Based on aggregated 13F filings for Q2 2016.